Browse > Article

Effects of Isotlavones Supplemented Diet on Lipid Concentrations and Hepatic LDL Receptor mRNA Level in Growing Female Rats  

Choi Mi-Ja (Department of Food and Nutrition, Keimyung University, Department of Health and Medicinal Food, World Cyber College)
Jo Hyun-Ju (Department of Food and Nutrition, Keimyung University, Department of Health and Medicinal Food, World Cyber College)
Publication Information
Journal of Nutrition and Health / v.38, no.5, 2005 , pp. 344-351 More about this Journal
Abstract
The purpose of this study was to examine the impact of isoflavones on lipid concentrations and hepatic LDL receptor mRNA level in growing female rats. Twenty four rats (body weight $75\pm5g$) were randomly assigned to one of two groups, consuming control diet or isoflavones supplemented diet (57mg isoflavones/100g diet). All rats has been fed on experimental diet and deionized water ad libitum for 9 weeks. The concentration of triglyceride and total cholesterol were measured in serum and liver. Serum HDL cholesterol was measured. Hepatic LDL receptor mRNA level was tested by RT-PCR. Supplementation of isoflavones did not affect weight gain, mean food intake and food efficiency ratio. Serum total cholesterol and non-HDL cholesterol of isoflavones supplemented rats were significantly lower than those of control rats (p<0.05). But hepatic cholseterol was not influenced by supplementation of isoflavones. Hepatic LDL receptor mRNA level not significantly different between control group and isoflavones supplemented group. Therefore, isoflavones may be beneficial on serum cholesterol and non-HDL cholesterol lowering in growing female rats.
Keywords
isoflavones; serum lipids; LDL receptor mRNA; growing female rat.;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kritchevsky D. Dietary protein and experimental atherosclerosis. Ann NYAcad Sci 676: 180-187, 1993   DOI
2 Huff MW, Carroll KK. Effects of dietary proteins and amino acid mixtures on plasma cholesterol levels in rabbits. J Nutr 110: 1676-1685,1980
3 Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr 28: 764-774,1975
4 Sidhy GS, Oakenfull DG. A mechanism for the hypocholesterolemic activity of saponins. Br J Nutr 55: 643-649, 1986   DOI   ScienceOn
5 Miksick RI. Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Bioi Med 208: 44-50, 1995
6 Kuiper GJM, Lemmen JG, Calsson B. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor $\beta$. Endocrinology 139: 4252-4263, 1998   DOI   ScienceOn
7 Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N, Shimizu H. Hypocholesterolemic effect of soy milk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31: 308-314, 2000   DOI   ScienceOn
8 Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S. The health consequences of early soy consumption. J Nutr 132 (suppI) : 559s-565s, 2002
9 Choi MJ, Cho HJ. Effects of soy isoflavones on bone mineral density in growing female rats. Korean J Nutrition 36: 359-367, 2003
10 Haglund O, Loustarinen R, Wallin R, Wibell I, Saldeen T. The effect of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin. Eur J Nutr 121: 165-172,1991
11 Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR) : trends and problems. J Mol Endocrinol 29: 23-39, 2002   DOI   PUBMED   ScienceOn
12 A1jmandi AH, Getlinger MJ, Goyal NV, Alekel L, Hasler CL, Juma S, Drum ML, Hollis BW, Kukreja Sc. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian honnone deficiency in rats. Am J Clin Nutr 68 (suppI) : 1358s-1363s, 1998
13 Lichtenstein AH. Soy protein, isoflavonoids, and risk of developing coronary heart disease. Curr Taheroscler Rep 1: 210 -214, 1999   DOI   PUBMED   ScienceOn
14 Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science 191: 150-154, 1976   DOI   PUBMED
15 Schouw IT, Kliijn MJ, Peeters PH, Grobbee DE. Phytoestrogens and cardiovascular disease risk. Nutr Metab Cardiovasc Dis 10: 154-167,2000
16 Kurowska EM, Carroll KK. Hypercholesterolemic responses in rabbits to selected groups of dietary essential amino acids. J Nutr 124: 364-370,1994
17 Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25: 1709-1714,2002   DOI   ScienceOn
18 Balmir F, Staack R, Jeffrey E, Jimenz MOB, Wang L, Potter SM. An extract of soy flour influences serum cholesterol and thyroid honnones in rats and hamsters. J Nutr 126: 3046-3053, 1996
19 Strong JP, Malcom GT, McMahan CA. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA 281: 727- 735, 1999   DOI   ScienceOn
20 Shorey RL, Day PJ, Willis RA. Effects of soybean polysaccharide on plasma lipids. J Am Diet Assoc 85: 1461-1465, 1985
21 Wong WW, Smith EO, Stuff IE, Hachey DL, Heird WC. Cholesterol lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 68 (suppI): 1385s-1389s, 1998
22 Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 366 (Pt 2) : 531-539, 2002   DOI   ScienceOn
23 Carroll KK, Kurowska EM. Soy consumption and cholesterol reduction: Review of animal and human studies. J Nutr 125 (suppI) : 594s-597s, 1995
24 Lovati MR, Manwni C, Canavesi A. Soybean protein diet increases low density lipoptotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80: 1498-1502, 1987   DOI
25 Makela S, Davis VL, Tally we. Dietary estrogens act through estrogen receptor mediated processes and show no anti-estrogenicity in cultured breast cancer cells. Environ Health Perspect 102: 572-578, 1994
26 Baum JA, Teng H, Erdman JW Jr. Long-tenn intake of soy protein improves blood lipid proftles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68: 545-551, 1998
27 Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J. Requirement of Sp 1 and estrogen receptor alpha interaction in 17 beta-estradiol mediated transcription activation of the low density lipoprotein receptor gene expression. Endocrinology 142: 1546-1553, 2001   DOI   PUBMED   ScienceOn
28 Tavia G, William BK. Menopause and coronary heart disease: Framingham study. Ann Intern Med 89: 157-161, 1978
29 Folch J, Lees M, Sloanestanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J BioI Chem 226: 497-509,1957
30 Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 46: 221-226, 2001
31 Martin RM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 198: 1860-1867, 1978
32 Picherit C, Bennetau-Pelissero C, Chanternne B, Lebecque P, Cavicco MJ, Barlet JP, Coxam V. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131: 723-728, 2001
33 Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: Potential mechanisms. Am J Clin Nutr 68 (suppI) : 1930s-1933s, 1998
34 Anthony MS, Clarkson TB, Hughes, CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126: 43-50, 1996
35 Dwyer IT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94: 739-743, 1994   DOI   ScienceOn
36 Zhan S, Ho Sc. Meta-analysis of the effects of soy protein containing isoflavones on the lipid proftle. Am J Clin Nutr 81: 397-408,2005
37 Messina M, Messina V. Soyfoods, soybean isoflavones, and health: A brief overview. J Ren Nutr 10: 63-68, 2000   DOI   ScienceOn
38 Kim MS. Beneficial effect of soy isoflavone on bone loss and hyperlipidemia in ovariectomized rats. Ph D Dissertation. Seoul National University, Seoul, 1999
39 Sirtori CR, Lovati MR, Manwni C. Soy and cholesterol reduction: Clinical experience. J Nutr 125 (suppI) : 598s-605s, 1995
40 Jayo MI, Anthony MS, Register C, Rankin SE, Best T, Clarkson TB. Dietary soy isoflavones and bone loss; a study in ovariectomized monkeys. J Bone Mineral Res 11: s228 (abstr), 1996
41 Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in nonnochoiesterrolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73: 225-231,2001
42 Teixeira BH. Effects of feeding 4 levels of soy protein for 3 and 6 week on blood lipids. Am J Clin Nutr 71: 1074-1084,2000
43 National institutes of health, national heart, lung, and blood institute. Report of the expert panel or blood cholesterol levels in children and adolescents. National Cholesterol Education Program. Bethesda. Nlli Publication No. 91-27-32, 1991
44 Merz-Demlow BE, Duncam AM, Wangen KE, Carr TP, Xu X. Soy isoflavones improve plasma lipid in nonnochoiesterolemic premenopausal women. Am J Clin Nutr 71: 1462-1469, 2000
45 Goodman GD, Kritz SD. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131: 1202-1206, 2001
46 Setchel KDR, Nechemias LZ, Cai J, Heubi IE. Isoflavones content of infant formulas and the metabolic rate of these phytoestrogens in early life. Am J Clin Nutr 68 (suppI) : 1453s-1461s, 1998
47 Reeves PG, Nielsen PH, Fahey GC. AIN-93 purified diets for laboratory rodents. J Nutr 123: 1939-1951, 1993